A detailed history of Magnus Financial Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Magnus Financial Group LLC holds 5,814 shares of LLY stock, worth $4.35 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
5,814
Previous 6,081 4.39%
Holding current value
$4.35 Million
Previous $5.51 Million 6.45%
% of portfolio
0.53%
Previous 0.62%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$772.14 - $960.02 $206,161 - $256,325
-267 Reduced 4.39%
5,814 $5.15 Million
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $380,556 - $477,246
525 Added 9.45%
6,081 $5.51 Million
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $81,723 - $109,334
138 Added 2.55%
5,556 $4.32 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $85,605 - $100,918
163 Added 3.1%
5,418 $3.16 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $22,604 - $31,163
52 Added 1.0%
5,255 $2.82 Million
Q2 2023

Jul 19, 2023

BUY
$350.74 - $468.98 $14,731 - $19,697
42 Added 0.81%
5,203 $2.44 Million
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $92,878 - $109,081
299 Added 6.15%
5,161 $1.77 Million
Q4 2022

Feb 02, 2023

BUY
$321.55 - $374.67 $33,762 - $39,340
105 Added 2.21%
4,862 $1.78 Million
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $229,772 - $261,849
775 Added 19.46%
4,757 $1.54 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $132,396 - $155,453
475 Added 13.54%
3,982 $1.29 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $155,364 - $193,078
662 Added 23.27%
3,507 $1 Million
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $91,064 - $113,011
405 Added 16.6%
2,845 $786,000
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $1,551 - $1,908
7 Added 0.29%
2,440 $564,000
Q2 2021

Aug 06, 2021

BUY
$180.55 - $233.54 $120,065 - $155,304
665 Added 37.61%
2,433 $558,000
Q1 2021

May 05, 2021

SELL
$164.32 - $212.72 $334,719 - $433,310
-2,037 Reduced 53.53%
1,768 $330,000
Q4 2020

Feb 05, 2021

BUY
$130.46 - $172.63 $11,610 - $15,364
89 Added 2.4%
3,805 $643,000
Q3 2020

Nov 05, 2020

SELL
$146.22 - $169.13 $191,109 - $221,052
-1,307 Reduced 26.02%
3,716 $550,000
Q2 2020

Aug 11, 2020

BUY
$136.42 - $164.18 $818 - $985
6 Added 0.12%
5,023 $825,000
Q1 2020

May 11, 2020

BUY
$119.05 - $147.35 $12,024 - $14,882
101 Added 2.05%
5,017 $696,000
Q4 2019

Jan 28, 2020

BUY
$106.92 - $132.43 $11,868 - $14,699
111 Added 2.31%
4,916 $646,000
Q3 2019

Nov 08, 2019

BUY
$106.79 - $116.16 $4,378 - $4,762
41 Added 0.86%
4,805 $537,000
Q2 2019

Aug 05, 2019

BUY
$110.79 - $129.32 $775 - $905
7 Added 0.15%
4,764 $528,000
Q1 2019

May 09, 2019

BUY
$111.31 - $131.02 $779 - $917
7 Added 0.15%
4,757 $617,000
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $503,025 - $563,540
4,750 New
4,750 $550,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Magnus Financial Group LLC Portfolio

Follow Magnus Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.